Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

Stability & shelf life

The product degraded or failed stability testing before its labeled expiry. Heat, moisture or time can break the drug down into degradants or reduce potency.

560 FDA drug recalls with this cause, newest first.

These recalls involve products whose stability data no longer supports the expiry date on the label, or that failed a stability test before that date. A medicine that loses potency early does not just stop working as well; it can also change chemically into something FDA never approved. The fix is usually a shorter shelf life for future lots.

Class II · Moderate risk

Desoximetasone Ointment USP

cGMP deviations: all products within expiry are being recalled because the firm is discontinuing its stability study program.

Terminated Stability / shelf life Teligent Pharma, Inc. NDC 52565-045-99 D-0677-2022
Class II · Moderate risk

Desoximetasone Ointment USP

cGMP deviations: all products within expiry are being recalled because the firm is discontinuing its stability study program.

Terminated Stability / shelf life Teligent Pharma, Inc. NDC 70512-037-10 D-0676-2022
Class II · Moderate risk

Desonide Ointment

cGMP deviations: all products within expiry are being recalled because the firm is discontinuing its stability study program.

Terminated Stability / shelf life Teligent Pharma, Inc. NDC 52565-038-15 D-0675-2022
Class II · Moderate risk

Clobetasol Propionate Gel

cGMP deviations: all products within expiry are being recalled because the firm is discontinuing its stability study program.

Terminated Stability / shelf life Teligent Pharma, Inc. NDC 52565-082-15 D-0674-2022
Class II · Moderate risk

Clobetasol Propionate Ointment USP

cGMP deviations: all products within expiry are being recalled because the firm is discontinuing its stability study program.

Terminated Stability / shelf life Teligent Pharma, Inc. NDC 52565-039-15 D-0673-2022
Class II · Moderate risk

Clobetasol Propionate Lotion

cGMP deviations: all products within expiry are being recalled because the firm is discontinuing its stability study program.

Terminated Stability / shelf life Teligent Pharma, Inc. NDC 52565-055-02 D-0672-2022
Class II · Moderate risk

Clobetasol Propionate Cream USP

cGMP deviations: all products within expiry are being recalled because the firm is discontinuing its stability study program.

Terminated Stability / shelf life Teligent Pharma, Inc. NDC 52565-094-15 D-0671-2022
Class II · Moderate risk

Clobetasol Propionate Cream USP

cGMP deviations: all products within expiry are being recalled because the firm is discontinuing its stability study program.

Terminated Stability / shelf life Teligent Pharma, Inc. NDC 52565-051-15 D-0670-2022
Class III · Low risk

Bortezomib

Failed stability specifications

Terminated Stability / shelf life Dr. Reddy's Laboratories, Inc. NDC 43598-865-60 D-0577-2022
Class III · Low risk

Azacitidine

Failed stability specifications

Terminated Stability / shelf life Dr. Reddy's Laboratories, Inc. NDC 43598-465-62 D-0576-2022
Class III · Low risk

Azacitidine

Failed stability specifications

Terminated Stability / shelf life Dr. Reddy's Laboratories, Inc. NDC 43598-305-62 D-0575-2022
Class III · Low risk

Gatifloxacin Ophthalmic Solution

Failed Stability Specifications: Out-of-specification results observed in a water loss test that might affect the assay content and alter drug concentration.

Terminated Stability / shelf life Lupin Pharmaceuticals Inc. NDC 68180-435-01 D-0326-2022
Class II · Moderate risk

Pain Aid Esf-

CGMP Deviations: failed stability results, inadequate laboratory investigations,

Terminated Stability / shelf life ULTRAtab Laboratories, Inc. NDC 62959-560-00 D-0327-2022
Class III · Low risk

Gatifloxacin Ophthalmic Solution

Failed Stability Specifications: Out-of-specification results observed in a water loss test that might affect the assay content and alter drug concentration.

Terminated Stability / shelf life Lupin Pharmaceuticals Inc. NDC 68180-435-01 D-0091-2022
Class III · Low risk

AERO Tab PAIN RELIEVER

Failed Stability Specifications: Out-of-Specification results observed for Aspirin related compound Salicylic Acid.

Terminated Stability / shelf life Ultra Seal Corporation D-0073-2022
Class III · Low risk

Vica-Cet BACK PAIN RELIEF

Failed Stability Specifications: Out-of-Specification results observed for Aspirin related compound Salicylic Acid.

Terminated Stability / shelf life Ultra Seal Corporation D-0071-2022
Class III · Low risk

PainAway II

Failed Stability Specifications: Out-of-Specification results observed for Aspirin related compound Salicylic Acid.

Terminated Stability / shelf life Ultra Seal Corporation D-0070-2022
Class II · Moderate risk

Betamethasone Dipropionate Lotion USP

Failed Stability Specifications: lot did not meet specification for the Active Pharmaceutical Ingredient (API) particle test, which was determined through routine stability testing

Terminated Stability / shelf life Teligent Pharma, Inc. NDC 52565-023-29 D-0297-2022